10-K/A: Amesite Inc. Amends 10-K to Report Material Weaknesses in Internal Controls

Amesite Inc. has amended its annual report to disclose material weaknesses in its internal control over financial reporting as of June 30, 2024.

Summary

• Amesite Inc. filed an amendment to its original 10-K report for the fiscal year ended June 30, 2024, to correct sections regarding internal control over financial reporting.
• Management concluded that internal controls were not effective due to material weaknesses, including a lack of controls for reviewing journal entries and calculating stock compensation expenses.
• The company also lacked controls over the classification of stock-based compensation and the recording of deferred revenue.
• The amendment includes new certifications from the CEO and CFO.
• The original 10-K's forward-looking statements were not revised to reflect events after the original filing date.
• The company's mission is to empower people with AI tools, focusing on higher education and healthcare sectors.
• Amesite's higher education platform, Amesite Engage, enables institutions to offer professional skills courses.
• NurseMagic, their healthcare app, supports nurses and caregivers with job-related tasks and stress management.
• The company offers a free version of NurseMagic to gather user feedback and improve the product.
• Amesite targets healthcare organizations with staffing challenges, offering an enterprise version of NurseMagic.
• They estimate a potential 15x return on investment for healthcare enterprises using NurseMagic.
• In higher education, Amesite targets community colleges, offering a no-fee setup and managing the entire system.
• The company has received eleven U.S. patents and has four pending applications.
• Amesite faces competition from major Electronic Medical Record companies in healthcare and Online Program Management firms in higher education.
• The company is subject to healthcare and education regulations, including HIPAA and data privacy laws.
• Amesite had a net loss of $4,403,182 for the year ended June 30, 2024, compared to a net loss of $4,153,303 in the previous year.
• Revenue decreased to $166,881 in 2024 from $845,009 in 2023, due to a strategic pivot to grow the customer base.
• General and administrative expenses increased to $2,908,289 in 2024 from $2,492,777 in 2023.
• Technology and content development expenses decreased to $1,074,000 in 2024 from $1,523,547 in 2023.
• Sales and marketing expenses decreased to $763,915 in 2024 from $1,053,193 in 2023.
• The company's cash balance was $2,171,016 as of June 30, 2024.
• Management has expressed substantial doubt about the company's ability to continue as a going concern.

Sentiment

Score: 3

Explanation: The document reveals significant financial and operational challenges, including material weaknesses in internal controls, a substantial revenue decline, and management's doubt about the company's ability to continue as a going concern. While there are some positive aspects, the overall tone is negative from an investment perspective.

Positives

• Amesite has a strong focus on AI-powered solutions for both higher education and healthcare.
• The NurseMagic app has a free version to gather user feedback and improve the product.
• The company estimates a potential 15x return on investment for healthcare enterprises using NurseMagic.
• Amesite offers a no-fee setup for community colleges using their higher education platform.
• The company has a portfolio of eleven U.S. patents and four pending applications.
• Amesite has a diverse management team with 66% female and 33% racially diverse representation.

Negatives

• Amesite reported material weaknesses in its internal control over financial reporting.
• The company experienced a significant decrease in revenue from $845,009 in 2023 to $166,881 in 2024.
• Amesite incurred a net loss of $4,403,182 for the year ended June 30, 2024.
• Management has expressed substantial doubt about the company's ability to continue as a going concern.
• The healthcare app, NurseMagic, is currently not HIPAA compliant, posing regulatory risks.
• The company relies on pilot programs and free versions of its app, which may not convert to enterprise licenses.
• Amesite faces intense competition in both the healthcare and higher education software markets.

Risks

• The company faces significant compliance and regulatory risks, particularly in the healthcare sector with HIPAA.
• Amesite may struggle to gain market adoption and win customers from competitors in both healthcare and higher education.
• The company has a limited operating history in online programs and may fail to grow its customer base.
• Amesite is dependent on key management personnel, and the loss of such individuals could hamper operations.
• The company's operating results are susceptible to fluctuations due to factors beyond their control.
• Amesite has a history of losses and will need substantial additional funding to continue operations.
• The company may engage in future acquisitions that could disrupt the business and dilute stockholders.
• Cybersecurity risks and the failure to maintain data integrity could result in damages and lawsuits.
• Unfavorable global economic conditions could adversely affect the company's business and financial condition.
• The company's stock price may be volatile, and an active trading market may not be sustained.
• The company may be at risk of securities class action litigation.
• Failure to maintain effective internal controls could cause investors to lose confidence.
• The company's principal stockholders and management own a significant percentage of stock, which could lead to conflicts of interest.
• Certain provisions in the company's certificate of incorporation make it difficult for a third party to acquire them.

Future Outlook

The company plans to generate cash by completing financing transactions, which may include offerings of common stock, but these plans are subject to market conditions and are not within the company's control.

Management Comments

• Management concluded that, as of June 30, 2024, our internal control over financial reporting was not effective due to certain identified material weaknesses.
• Management believes that it may not have sufficient cash and cash equivalents to maintain the Company's planned operations for the next twelve months following the issuance of these financial statements.
• Management plans include generating cash by completing financing transactions, which may include offerings of common stock.

Industry Context

The document highlights the competitive landscape in both the healthcare and higher education software industries, noting the presence of major players and the rapid evolution of technologies. The company's focus on AI-powered solutions positions it within a growing trend of technology integration in these sectors.

Comparison to Industry Standards

• Amesite's revenue decline contrasts with the growth seen in many SaaS companies, particularly in the edtech sector, where the shift to online learning has been accelerated.
• The reported material weaknesses in internal controls are a significant concern, as most public companies, especially those listed on Nasdaq, are expected to have robust financial controls.
• The company's reliance on pilot programs and free versions of its app is a common strategy for early-stage tech companies, but the conversion rate to paying customers will be critical for long-term success.
• The estimated 15x ROI for healthcare enterprises using NurseMagic is a bold claim that needs to be validated with real-world data and customer testimonials.
• The company's focus on community colleges aligns with the growing emphasis on workforce development, but the competition in this space is intense, with many established players offering similar solutions.
• Compared to established players in the healthcare software market, Amesite's NurseMagic app is still in its early stages and needs to demonstrate compliance with regulations like HIPAA to gain wider adoption.
• The company's net loss and negative cash flow from operations are not uncommon for early-stage tech companies, but the management's doubt about the company's ability to continue as a going concern is a serious red flag.

Stakeholder Impact

• Shareholders face significant risks due to the company's financial instability and material weaknesses in internal controls.
• Employees may experience uncertainty due to the company's financial challenges and potential restructuring.
• Customers may be concerned about the company's ability to deliver consistent and reliable services.
• Suppliers and creditors may face increased risks due to the company's financial instability.

Next Steps

• The company will take steps to remediate the material weaknesses through the documentation of processes and controls.
• The company will formalize its process and documentation for monitoring internal control over financial reporting.
• Management will continue to review and make necessary changes to the overall design of the company's internal control environment.
• The company plans to generate cash by completing financing transactions, which may include offerings of common stock.

Key Dates

Keywords

AI, Artificial Intelligence, Healthcare, Higher Education, NurseMagic, Amesite Engage, Internal Controls, Software, EdTech, eLearning, Patents, HIPAA, Regulatory Compliance, Financial Reporting, Material Weakness